Cougar Biotechnology's Board of Directors Recommends Stockholders Accept Johnson & Johnson's $43.00 Per Share Cash Tender Offer.
Linked as:
Extract
Cougar Biotechnology's Board of Directors Recommends Stockholders Accept Johnson & Johnson's $43.00 Per Share Cash Tender Offer.
LOS ANGELES -- In first graph, first sentence of release, stock exchange for Johnson & Johnson, should read: NYSE (sted NASDAQ).
The corrected release reads: COUGAR BIOTECHNOLOGY...See the full content of this document
Sponsored links
